PERCEPTIVE ADVISORS LLC 13D and 13G filings for Inhibrx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:50 pm Sale |
2024-05-30 | 13G | Inhibrx Biosciences, Inc. INBX |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-4,776,306 (Position Closed) |
Filing |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
PERCEPTIVE ADVISORS LLC | 4,776,306 9.900% |
1,462,523 (+44.13%) |
Filing |
| 2023-02-14 2:35 pm Purchase |
2022-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
PERCEPTIVE ADVISORS LLC | 3,313,783 7.600% |
1,345,039 (+68.32%) |
Filing |
| 2022-07-18 8:59 pm Purchase |
2022-07-05 | 13G | Inhibrx Biosciences, Inc. INBX |
PERCEPTIVE ADVISORS LLC | 1,968,744 5.000% |
1,968,744 (New Position) |
Filing |